Please use this identifier to cite or link to this item:
https://hdl.handle.net/11499/5770
Title: | Development of reversible posterior leukoencephalopathy syndrome after cyclophosphamide treatment in a patient with lupus nephritis | Authors: | Yildiz, S. Güçlü, A. Degirmenci, E. Kiroglu, Y. Yalçin, N. Çobankara, V. Topaloglu, M. Erürker, Muammer |
Keywords: | Cyclophosphamide Lupus nephritis Reversible posterior leucoencephalopathy syndrome |
Abstract: | Renal involvement in systemic lupus erythematosus is a frequent and serious complication that significantly increases morbidity and mortality. Despite all studies and usage of new drugs, treatment of lupus nephritis continues to be a problem. Diffuse proliferative lupus nephritis has a poor prognosis and aggressive treatment must be undertaken. Cyclophosphamide is commonly used in treatment despite its side effects. Reversible posterior leucoencephalopathy syndrome is a clinico-radiological syndrome manifested by blood pressure elevation, headache, visual disturbances, confusion, seizures and sometimes focal neurological signs that can develop due to usage of cytotoxic drugs. We present a case of lupus nephritis in which reversible posterior leucoencephalopathy syndrome developed after intravenous cyclophosphamide administration and recovered spontaneously by symptomatic treatment in this article. | URI: | https://hdl.handle.net/11499/5770 https://doi.org/10.5262/tndt.2011.1001.19 |
ISSN: | 1300-7718 |
Appears in Collections: | Scopus İndeksli Yayınlar Koleksiyonu / Scopus Indexed Publications Collection Tıp Fakültesi Koleksiyonu TR Dizin İndeksli Yayınlar Koleksiyonu / TR Dizin Indexed Publications Collection WoS İndeksli Yayınlar Koleksiyonu / WoS Indexed Publications Collection |
Files in This Item:
File | Size | Format | |
---|---|---|---|
bd55f36b-020f-4bac-adcf-f97aa6e06994.pdf | 321.74 kB | Adobe PDF | View/Open |
CORE Recommender
Page view(s)
60
checked on Aug 24, 2024
Download(s)
20
checked on Aug 24, 2024
Google ScholarTM
Check
Altmetric
Items in GCRIS Repository are protected by copyright, with all rights reserved, unless otherwise indicated.